0001213900-18-011202.txt : 20180815 0001213900-18-011202.hdr.sgml : 20180815 20180815164831 ACCESSION NUMBER: 0001213900-18-011202 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 EFFECTIVENESS DATE: 20180815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Icagen, Inc. CENTRAL INDEX KEY: 0001518520 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200982060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-319373 FILM NUMBER: 181021474 BUSINESS ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-941-5206 MAIL ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: XRpro Sciences, Inc. DATE OF NAME CHANGE: 20141204 FORMER COMPANY: FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc DATE OF NAME CHANGE: 20110419 D 1 primary_doc.xml X0708 D LIVE 0001518520 Icagen, Inc. 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC NORTH CAROLINA 27703 919-941-5206 DELAWARE Caldera Pharmaceuticals, Inc. XRpro Sciences, Inc. Caldera Pharmaceuticals Inc Corporation true Richard Cunningham 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Executive Officer Mark Korb 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Executive Officer Douglas Krafte 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Executive Officer Timothy Tyson 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Director Clive Kabatznik 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Director Michael Taglich 275 Madison Avenue Suite 1618 New York NY NEW YORK 10016 Director Vincent Palmieri 275 Madison Avenue Suite 1618 New York NY NEW YORK 10016 Director Edward Roffman 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Director Pharmaceuticals Decline to Disclose 06b false 2018-08-13 false true true false 10000 1500000 500000 1000000 false 4 0 0 0 true *Proceeds may be used to pay overhead and other corporate expenses which could include salaries false Icagen, Inc. /s/ Richard Cunningham Richard Cunningham Chief Executive Officer 2018-08-15